These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 22562075)
21. Finding the right time for weaning off immunosuppression in solid organ transplant recipients. Orlando G Expert Rev Clin Immunol; 2010 Nov; 6(6):879-92. PubMed ID: 20979553 [TBL] [Abstract][Full Text] [Related]
22. New strategies in immunosuppression. Regazzi MB; Alessiani M; Rinaldi M Transplant Proc; 2005; 37(6):2675-8. PubMed ID: 16182781 [TBL] [Abstract][Full Text] [Related]
23. The role and value of sirolimus administration in kidney and liver transplantation. Mehrabi A; Fonouni H; Kashfi A; Schmied BM; Morath Ch; Sadeghi M; Schemmer P; Encke J; Sauer P; Zeier M; Weitz J; Büchler MW; Schmidt J Clin Transplant; 2006; 20 Suppl 17():30-43. PubMed ID: 17100699 [TBL] [Abstract][Full Text] [Related]
25. [Post-transplantation malignant tumors and the challenges of immunosuppressive therapy in transplanted patients developing lymphoma. Mycophenolic acid as a possibility]. Végso G Magy Onkol; 2009 Jun; 53(2):149-56. PubMed ID: 19581181 [TBL] [Abstract][Full Text] [Related]
26. The new immunosuppressive era. Lo Monte AI; Ciancio G; Burke G; Roth D; Miller J Ann Ital Chir; 1999; 70(1):1-19. PubMed ID: 10367502 [TBL] [Abstract][Full Text] [Related]
27. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation. Armenti VT; Daller JA; Constantinescu S; Silva P; Radomski JS; Moritz MJ; Gaughan WJ; McGrory CH; Coscia LA Clin Transpl; 2006; ():57-70. PubMed ID: 18368705 [TBL] [Abstract][Full Text] [Related]
28. New perspectives of immunosuppression. Halleck F; Friedersdorff F; Fuller TF; Matz M; Huber L; Dürr M; Schütz M; Budde K Transplant Proc; 2013 Apr; 45(3):1224-31. PubMed ID: 23622665 [TBL] [Abstract][Full Text] [Related]
29. Biomarkers as a tool for management of immunosuppression in transplant patients. Wieland E; Olbricht CJ; Süsal C; Gurragchaa P; Böhler T; Israeli M; Sommerer C; Budde K; Hartmann B; Shipkova M; Oellerich M Ther Drug Monit; 2010 Oct; 32(5):560-72. PubMed ID: 20814352 [TBL] [Abstract][Full Text] [Related]
34. [Low-toxicity immunosuppressive therapy in renal transplant]. Scolari F; La Manna G; Comai G; Cappuccilli ML; Todeschini P; Ciavatti A; Persici E; Feliciangeli G; Stefoni S G Ital Nefrol; 2007; 24 Suppl 38():44-8. PubMed ID: 17922447 [TBL] [Abstract][Full Text] [Related]
35. Current topics in immunotherapy and the role of the pharmacist on a solid organ transplant service. Shaefer MS Pharmacotherapy; 1991; 11(6):136S-141S. PubMed ID: 1771138 [TBL] [Abstract][Full Text] [Related]
36. Evidence for immunosuppression in lung transplantation. Hopkins PM; McNeil K Curr Opin Organ Transplant; 2008 Oct; 13(5):477-83. PubMed ID: 19060529 [TBL] [Abstract][Full Text] [Related]
37. The beginning of clinical tolerance in solid organ allografts. Monaco AP Exp Clin Transplant; 2004 Jun; 2(1):153-61. PubMed ID: 15859922 [TBL] [Abstract][Full Text] [Related]
38. Defining the risks for cytomegalovirus infection and disease after solid organ transplantation. Stratta RJ; Pietrangeli C; Baillie GM Pharmacotherapy; 2010 Feb; 30(2):144-57. PubMed ID: 20099989 [TBL] [Abstract][Full Text] [Related]
39. Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management. Pilch NA; Bowman LJ; Taber DJ Pharmacotherapy; 2021 Jan; 41(1):119-131. PubMed ID: 33131123 [TBL] [Abstract][Full Text] [Related]
40. [Modern immunosuppression after solid organ transplantation]. Beimler J; Morath C; Zeier M Internist (Berl); 2014 Feb; 55(2):212-22. PubMed ID: 24518922 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]